The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
rac-Ethyl 4-(4-(benzyloxy)-3-methoxyphenyl)-6-methyl-2-oxo-1,2,3,4-tetrahydropyrimidine-5-carboxylate ID: ALA2385908
Max Phase: Preclinical
Molecular Formula: C22H24N2O5
Molecular Weight: 396.44
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CCOC(=O)C1=C(C)NC(=O)NC1c1ccc(OCc2ccccc2)c(OC)c1
Standard InChI: InChI=1S/C22H24N2O5/c1-4-28-21(25)19-14(2)23-22(26)24-20(19)16-10-11-17(18(12-16)27-3)29-13-15-8-6-5-7-9-15/h5-12,20H,4,13H2,1-3H3,(H2,23,24,26)
Standard InChI Key: NQQNHUALWFENLG-UHFFFAOYSA-N
Molfile:
RDKit 2D
29 31 0 0 0 0 0 0 0 0999 V2000
15.8819 -28.7601 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.5956 -28.3464 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
17.3108 -28.7578 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.3074 -29.5813 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.0218 -29.9926 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.7366 -29.5789 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.7326 -28.7496 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.0178 -28.3420 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.0122 -27.5170 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
17.2949 -27.1093 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.4523 -29.9894 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.4510 -30.8191 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.1625 -31.2294 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.8782 -30.8183 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.8778 -29.9923 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.1617 -29.5774 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.1618 -32.0544 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
21.5925 -29.5802 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.1613 -28.7523 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.8756 -28.3395 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
19.4466 -28.3402 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
21.5903 -28.7516 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.3046 -28.3388 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.1667 -28.3487 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.1677 -27.5244 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.4534 -27.1131 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.7385 -27.5268 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.7425 -28.3561 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.4573 -28.7636 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 7 1 0
7 8 2 0
8 3 1 0
8 9 1 0
9 10 1 0
11 6 1 0
11 12 1 0
11 16 1 0
12 13 1 0
13 14 1 0
14 15 1 0
15 16 2 0
13 17 2 0
15 18 1 0
16 19 1 0
19 20 1 0
19 21 2 0
20 22 1 0
22 23 1 0
1 24 1 0
24 25 2 0
25 26 1 0
26 27 2 0
27 28 1 0
28 29 2 0
29 24 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 396.44Molecular Weight (Monoisotopic): 396.1685AlogP: 3.47#Rotatable Bonds: 7Polar Surface Area: 85.89Molecular Species: NEUTRALHBA: 5HBD: 2#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 12.57CX Basic pKa: ┄CX LogP: 2.65CX LogD: 2.65Aromatic Rings: 2Heavy Atoms: 29QED Weighted: 0.70Np Likeness Score: -0.75
References 1. Dubernet M, Duguet N, Colliandre L, Berini C, Helleboid S, Bourotte M, Daillet M, Maingot L, Daix S, Delhomel JF, Morin-Allory L, Routier S, Walczak R.. (2013) Identification of New Nonsteroidal RORα Ligands; Related Structure-Activity Relationships and Docking Studies., 4 (6): [PMID:24900700 ] [10.1021/ml300471d ] 2. Li Z, Liu T, He X, Bai C.. (2022) The evolution paths of some reprehensive scaffolds of RORγt modulators, a perspective from medicinal chemistry., 228 [PMID:34776280 ] [10.1016/j.ejmech.2021.113962 ]